| Literature DB >> 34603480 |
Tao Wang1, Jianxia Zhai1, Xian-Liang Liu1, Li-Qun Yao1, Jing-Yu Benjamin Tan1.
Abstract
BACKGROUND: Fatigue is one of the most common symptoms among breast cancer survivors. Although massage therapy has been commonly used for fatigue management, relevant evidence on the effectiveness of massage therapy for the reduction of fatigue in breast cancer survivors is still unclear.Entities:
Year: 2021 PMID: 34603480 PMCID: PMC8483909 DOI: 10.1155/2021/9967574
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
A representative search strategy (PubMed).
| ID | Search strategy |
|---|---|
| #1 | “massage”[MeSH Terms] |
| #2 | (((“massage”[Title/Abstract]) OR (“massage therapy”[Title/Abstract])) OR (“massage therapies”[Title/Abstract])) OR (“tuina”[Title/Abstract]) |
| #3 | #1 OR #2 |
| #4 | (“fatigue”[MeSH Terms]) OR (lassitude[MeSH Terms]) |
| #5 | ((((((“fatigue”[Title/Abstract]) OR (lassitude[Title/Abstract])) OR (tired |
| #6 | #4 OR #5 |
| #7 | breast neoplasms[MeSH Terms] |
| #8 | (((((((“breast neoplasms”[Title/Abstract]) OR (“breast neoplasm”[Title/Abstract])) OR (“breast tumors”[Title/Abstract])) OR (“breast tumor”[Title/Abstract])) OR (“breast cancer”[Title/Abstract])) OR (“breast carcinoma”[Title/Abstract])) OR (“mammary tumor”[Title/Abstract])) OR (“mammary cancers”[Title/Abstract]) |
| #9 | #7 OR #8 |
| #10 | #3 AND #6 AND #9 |
Figure 1PRISMA flow diagram of the study selection. Adapted from: Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 71, 372.
Characteristics of the included studies.
| Study | Country | Study design | Cancer stage | Sample size and age | Intervention | Control | Outcomes |
|---|---|---|---|---|---|---|---|
| S1: [ | Iran | Double-blind RCT | Stage I | Randomized: 60 | Reflexology therapy | Routine treatment and care | Fatigue: Fatigue Severity Scale (FSS) |
| S2: [ | China | RCT | Stages I–IV | Randomized: 98 | Chinese massage therapy | Routine treatment and care | Fatigue: Chronic Fatigue Syndrome (CFS) |
| S3: [ | USA | Single-blind RCT, three groups | Stages 0–III | Randomized: 66 | Group A | Group B: light touch (LT) | Fatigue: Multidimensional Fatigue Inventory (MFI) + PROMIS Fatigue Short Form 7a (PROMIS) |
| S4: [ | Turkey | RCT | Stages I–III | Randomized: 60 | Reflexology therapy | Routine treatment and care | Fatigue: Brief Fatigue Inventory (BFI) |
| S5: [ | USA | RCT | Stages III and IV | Randomized: 256 (patient-caregiver dyads) | Reflexology therapy | Routine treatment and care | Fatigue: MD Anderson Symptom Inventory |
| S6: [ | Spain | Single-blind, placebo-controlled crossover design | Stage I–IIIa | Randomized: 20 (crossover design) | Myofascial massage | Routine treatment and care | Fatigue: Profile of Mood States (POMS) Questionnaire (fatigue subscale) |
| S7: [ | USA | Longitudinal, randomized clinical trial | Stages III and IV, or stages I and II with recurrence or metastasis | Randomized: 286 | Group A: reflexology therapy | Group B: lay foot manipulation (LFM) – light touch | Fatigue: Brief Fatigue Inventory (BFI) |
| S8: [ | USA | RCT | Any stage | Randomized: 45 | Group A: modified Swedish massage therapy | Group B: polarity therapy | Fatigue: Brief Fatigue Inventory (BFI) |
| S9 [ | Germany | RCT | Any stage | Randomized: 34 | Swedish massage therapy | Routine treatment and care | Fatigue: Berlin Mood Questionnaire (BSF; fatigue subscale) |
| S10: [ | Germany | RCT | Without distant metastases | Randomized: 115 | Swedish massage therapy | Routine treatment and care | Fatigue: |
Note. QoL = quality of life.
Description of massage therapy interventions.
| Study | Massage modality | Massage procedure | Intervention instructor | Timing of intervention | Intervention duration | Frequency | Follow-up |
|---|---|---|---|---|---|---|---|
| S1: [ | Reflexology therapy | Pressing the major reflexive points of the soles with the thumb and index finger in a worm-like movement | NR | After chemotherapy | 4 weeks | Twice per week, 20 min per session | No |
| S2: [ | Chinese massage therapy | (1) Massaging the patient's | Specialist nurses | After surgery | 3 months | Twice per week, around 30 min per session | No |
| S3: [ | Swedish massage therapy | SMT techniques using effleurage kneading of underlying muscles and tapotement | Licensed massage therapists | After primary treatment | 6 weeks | Weekly, 45 min per session | No |
| S4: [ | Reflexology therapy | (1) Performing primary relaxation techniques (effleurage, shaking, rotation, and stretching) on both feet | Trained researcher | During chemotherapy | Three sessions (one in each chemotherapy cycle, 21 days) | Around 30–40 min each session | No |
| S5: [ | Reflexology therapy | Performing nine reflexes on the foot with thumb-walking pressure | Trained caregivers | During chemotherapy, targeted, or hormonal therapy | 4 weeks | Weekly, 30 min per session | 11 weeks |
| S6: [ | Myofascial massage | Performing pressure, stroke, ear pull, and frontalis bone spread skills on the neck-shoulder area with the Barnes approach | Physical therapist | After coadjuvant treatment except hormone therapy | NR | Two occasions separated by a 2-week interval, 40 min per session | No |
| S7: [ | Reflexology therapy | Stimulating the nine essential reflexes specifically relating to breast cancer using reflexology (deep thumb-walking pressure) | Certified reflexologists | During chemotherapy | 4 weeks | Weekly, 30 min per session | No |
| S8: [ | Modified Swedish massage therapy | Applying strokes, including light moving touch, compression, and static holds technique | Licensed massage therapists | During radiation therapy | 3 weeks | Weekly, 30 min per session | No |
| S9: [ | Swedish massage therapy | Applying stroking, friction, kneading skills to the patients in a prone position. | Licensed, trained female massage therapist | After primary treatment | 5 weeks | Twice a week, 30 min per session | 11 weeks |
| S10: [ | Swedish massage therapy | Same as [ | Licensed, trained female massage therapist | After chemotherapy and/or radiation therapy | 5 weeks | Twice a week, 30 min per session | 11 weeks |
Note. NR = not reported.
Methodological quality appraisal of the included studies.
| Criteria | S1: [ | S2: [ | S3: [ | S4: [ | S5: [ | S6: [ | S7: [ | S8: [ | S9: [ | S10: [ | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Random sequence generation | ⨯ | ✓ | ✓ | ⨯ | ⨯ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 2 | Allocation concealment | ? | ? | ✓ | ? | ? | ✓ | ✓ | ? | ⨯ | ⨯ |
| 3 | Baseline assessment | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 4 | Blinding – participants | ? | ? | ⨯ | ? | ? | ⨯ | ✓ | ⨯ | ? | ? |
| 5 | Blinding – care provider | ? | ? | ⨯ | ? | ? | ⨯ | ✓ | ⨯ | ? | ? |
| 6 | Blinding – outcome | ? | ? | ✓ | ? | ? | ✓ | ✓ | ⨯ | ? | ? |
| 7 | Cointerventions | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ⨯ | ✓ | ✓ |
| 8 | Compliance | ✓ | ✓ | ✓ | ? | ✓ | ? | ✓ | ⨯ | ✓ | ✓ |
| 9 | Dropouts | ⨯ | ✓ | ✓ | ? | ✓ | ? | ✓ | ✓ | ✓ | ⨯ |
| 10 | Timing | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 11 | Selective outcome reporting | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 12 | Incomplete outcome data | ⨯ | ⨯ | ✓ | ? | ✓ | ? | ✓ | ⨯ | ⨯ | ⨯ |
|
|
| ||||||||||
| Sample size calculation | ? | ? | ✓ | ⨯ | ? | ✓ | ✓ | ? | ⨯ | ⨯ | |
| Inclusion criteria | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Exclusion criteria | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Evaluation of treatment effects | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Adverse events reporting | ⨯ | ⨯ | ✓ | ? | ? | ? | ✓ | ? | ✓ | ? | |
| Data analysis methods | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Note. ⨯: high risk; ✓: low risk; and ?: unclear.
Effects of the massage therapy on CRF.
| Study | Intervention (mean ± SE) | Control (mean ± SE) | Assessment time points | Fatigue outcome measures | Description of the effects |
|---|---|---|---|---|---|
| S1: [ | 20.66 ± 4.54 | 40.36 ± 9.58 | Postintervention (4 weeks) | Fatigue Severity Scale (FSS) | Significant difference was identified between the intervention and control groups ( |
| S2: [ | 2.63 ± 1.71 | 3.61 ± 2.16 | Postintervention (3 months) | Chronic Fatigue Syndrome (CFS) | Statistical differences were identified between the intervention and control groups ( |
| S3: [ | NR | NR | Postintervention (6 weeks) at visits 3 and 6 weeks | Multidimensional Fatigue Inventory (MFI) and Fatigue Short Form 7a (PROMIS) | |
| S4: [ | 1.20 ± 1.44 | 2.33 ± 1.65 | Postinterventions (every chemotherapy cycle) | Fatigue: Brief Fatigue Inventory (BFI) | Differences were observed between the intervention and control groups in the onset and first, second, and third measurements ( |
| S5: [ | Postintervention(4 weeks) | MD Anderson Symptom Inventory | Significant reduction in fatigue severity was identified in the intervention group compared with the control group beginning at weeks 2 and 3 ( | ||
| S6: [ | 41.3 ± 4.9 | 43.4 ± 7.0 | Postintervention | Fatigue: Profile of Mood States (POMS) Questionnaire (fatigue subscale) | Significant reduction in disturbance of mood and fatigue were observed after manual therapy ( |
| S7: [ | 5.9 ± 2.8 | LFM G: 5.4 ± 3 | Postintervention (4 weeks) | Brief Fatigue Inventory (BFI) | Significant reductions in fatigue severity in the intervention group was observed compared with the control group ( |
| S8: [ | Postintervention (4 weeks) | Brief Fatigue Inventory (BFI) | |||
| S9 [ | Postintervention (5 weeks) | Fatigue Severity Scale (FSS) | Improvement of tiredness nearly reached statistical significance immediately after intervention (T2; | ||
| S10: [ | NR | NR | Postintervention (5 weeks) | Giessen Inventory of Complaints (GBB; fatigue subscale) | Fatigue was improved at the end of the treatment ( |
Note. NR = not reported.